Nanjing Sanhome Pharmaceutical Business Development (project investment and collaboration) & Recruiting Event

  • August 20, 2016
  • 1:00 PM - 4:00 PM
  • LKSC 120, Stanford University, 291 Campus Drive, Palo Alto, CA 94305

Registration

Registration is closed

Please register for free to participate in this event. Please email icc@cabsweb.org for any questions.

Nanjing Sanhome Pharmaceutical Co., Ltd. Business Development & Recruiting Event in San Francisco

The chairman & CEO of Nanjing Sanhome Board, Dr. Yong Wang, with a group of 20 delegates from the Sanhome Board and Senior Management, will join a business development & recruiting event at 1:00 pm on Aug 20th at LKSC 120 Stanford University. 

Dr. Wang will introduce Sanhome Pharmaceutical and share his 20-year experience in establishing a pharma company in China and how to bring Class I innovation drug to China market.  Sanhome is:

  • l  Recruiting a CSO, who will be in charge of global R&D pipeline and overall operation, location: Nanjing
  • l  Recruiting principle and senior scientists in different departments, over 30 positions, location: Nanjing
  • l  Looking for merger and acquisition opportunities of therapeutic companies including preclinical and clinical trial projects and products
  • l  Looking for investment opportunity in biotech companies, including small molecule and large molecule therapeutics
  • l  Looking for other business partnering opportunities in new drug R&D to enrich the pipeline of Sanhome which has applied for IPO

Time & Location

  • ·         1:00 pm – 4:00 pm, Sunday, 20th August, 2016. Contact Phone:  317-504-6592.
  • ·         LKSC 120, Stanford University, 291 Campus Drive, Palo Alto, CA94305.

Organisers

  • ·         Nanjing Sanhome Pharmaceutical Co., Ltd. & Chinese American Bio/pharmaceutical Society.
  • ·         Thanks for the support from Association of Chinese Students and Scholars at Stanford.

Schedule

  • ·         1:00 – 1:30, Sign in and network
  • ·         1:30 – 1:40, Introduction of CABS
  • ·         1:40 – 2:40, Introduction of Sanhome, by the president, Dr. Yong WANG
  • ·         2:40 – 3:00, Q & A
  • ·         3:00 – 4:00, Refreshment & reception

Introduction

  • ·         Founded in 1996;
  • ·         At the end of this year, total employees expect to reach 2,500, 10-15% are R&D staffs including 200 with Ph.D. or Master degrees;
  • ·         R&D centre with over 8.6 acres, a pharmaceutical plant, a bulk pharmaceutical chemicals plant, a GAP level cultivation base, and with more than 400 branches or offices all over China;
  • ·         GMP certificated, ‘State high-tech innovation enterprise’ by China MST,  A top 100 pharmaceutical enterprise in China;
  • ·         Have developed 1st class new drugs and exclusive products, and holds 8 overseas patents, 34 China patents and more than 100 new drugs certificates;
  • ·         Undertakes ‘863’ and other national major projects, with a post-doctoral working station;
  • ·         R&D budget 200 million CNY this year, which represents 9% of the total sales; will increase to no less than 15% and the total R&D budget will be over 1 billion CNY within 5 years.

 

Requirements

  • ·         Chief Science Officer（CSO）：Ph.D. with 5-10 years of experiences in pharmaceutical industries;

Salary & welfare

  • ·         Benefits: free housing, stock, funding etc.

Contact:


南京圣和药业2016年8月20日旧金山专场招商招聘会

南京圣和药业王勇董事长帅圣和董事会和高管团队一行20人， 将于8月20日下午1:00到斯坦福大学李嘉诚中心召开圣和药业专场招商招聘活动。王勇董事长将亲自介绍圣和药业的发展现况和愿景，以及20年来他在圣和创业的经历，包括成功开发一个国家一类新药。圣和药业是国内拥有一类新药成功开发上市的不多的药企之一。圣和的研发和销售团队，成功经历了临床，上市，医保，招标，进医院，推广等新药在中国上市的每一个环节，他们的经验分享，能帮我们了解中国新药开发的历程。  

本次活动，圣和药业将：

  • l  在全球高薪聘请CSO首席科学家，全面负责圣和研发管线，和研发策略战略。
  • l  招聘高级研究员和资深研究员，R&D 各个职能部门，30个以上的职位
  • l  寻找收购并购的机会，包括制药项目或者公司，临床前或临床阶段。
  • l  寻找投资BIOTECH公司的机会，小分子和大分子制药项目。
  • l  公司处于排队上市的高速发展期，寻找各种合作方式，共同开发创新药PIPELINE。

时间地点

  • l  2016年8月20日星期六，下午1:00 – 4:00。联系电话：317-504-6592
  • l  斯坦福大学李嘉诚中心LKSC120，291 Campus Drive, Palo Alto, CA 94305

承办单位

  • l  南京圣和药业股份有限公司、中美生物医药协会     鸣谢：斯坦福中国学生学者联合会

活动流程

  • ·         1:00 – 1:30，报到登记
  • ·         1:30 – 1:40，中美生物医药协会介绍
  • ·         1:40 – 2:40，圣和药业介绍(董事长：王勇博士)
  • ·         2:40 – 3:00，提问环节
  • ·         3:00 – 4:00，交流活动，配有茶点

企业介绍

  • ·         始建于1996年；
  • ·         截至今年年底，员工总人数达2500人，研发人员占10-15%，其中博士、硕士200余人；
  • ·         研发中心占地2万平方米，公司另有中药材GAP种植基地、120亩原料药生产基地、100亩制剂厂、及遍布全国的400余个负责学术推广的办事处；
  • ·         第一批通过全国新版GMP认证，科技部“重点高新企业”、全国工商联评定“2015年中国医药制药业百强企业”；
  • ·         拥有国家一类新药、全国独家产品等，国外发明专利8项、国内发明专利34项、新药证书百余本；
  • ·         承担国家863项目、国家火炬计划等重点科研项目，拥有博士后工作站；
  • ·         今年研发预算2亿元，占总销售收入9%，五年后占比将不低于15%、研发投入绝对值将超10亿元。
  • ·         公司在证监会排队上市。
  •  

基本条件

  • ·         首席科学家CSO：博士学历，5-10年以上跨国或国外药企相关工作经验。
  •  

薪酬待遇

  • ·         首席科学家CSO，  工资面议。
  • ·         福利待遇：住房、股权、人才计划、餐饮等等。

联系方式：